Journal article
Multimorbidity, disease clusters and risk of all-cause and cause-specific mortality: a population-based prospective cohort study
- Abstract:
- The number of people living with ≥ two health conditions, termed multimorbidity, is increasing. We investigated the impact of multimorbidity on all-cause and cause-specific mortality risk in 502,370 UK Biobank participants aged 40 to 70 years. Participants attended an assessment centre between 2006 and 2010 and self-reported medical conditions during a nurse-led verbal interview. The presence of ≥ 2 long-term conditions from a preselected list of 43 conditions was used to define multimorbidity. In a training sample (80% of participants with multimorbidity), disease clusters were identified in four groups: women aged (1) 40–59 or (2) 60–70, and men aged (3) 40–59 or (4) 60–70. Mortality was ascertained from linkage to death records. Multivariate Cox proportional-hazards regression models were used to assess the association between multimorbidity and mortality adjusted for age, sex, ethnicity, socioeconomic status and education. Over a 16-year follow-up period (median = 13 years) dose–response associations were observed between number of multimorbid conditions and risk of all-cause mortality (n = 44,399 deaths), and particularly strong dose-response associations with cause-specific deaths due to cardiovascular and respiratory conditions. For women, a mental health/cancer/pain-related conditions cluster at ages 40–59 (Hazard Ratio [HR] = 2.61, 95% Confidence Interval [CI] 2.33–2.93), and a respiratory and pain-related conditions cluster at ages 60–70 (HR = 2.03, 95% CI 1.0–2.17), were associated with the greatest risk of mortality. For men, clusters of cardiometabolic conditions at ages 40–59 (HR = 3.43, 95% CI 3.14–3.74) and 60–70 (HR = 2.24, 95% CI 2.13–2.35) were associated with greater mortality risk. These findings suggest that understanding the impact of multimorbidity, and especially clusters of disease, is important for tailoring healthcare approaches for mortality risk reduction.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.2MB, Terms of use)
-
- Publisher copy:
- 10.1038/s41598-025-25285-w
Authors
- Publisher:
- Nature Research
- Journal:
- Scientific Reports More from this journal
- Volume:
- 15
- Issue:
- 1
- Article number:
- 41393
- Publication date:
- 2025-11-21
- Acceptance date:
- 2025-10-20
- DOI:
- EISSN:
-
2045-2322
- ISSN:
-
2045-2322
- Language:
-
English
- Pubs id:
-
2334182
- UUID:
-
uuid_0a102581-4a94-4d34-a1c9-f6e2904bb9f9
- Local pid:
-
pubs:2334182
- Source identifiers:
-
3496450
- Deposit date:
-
2025-11-21
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2025
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record